Burden of Disease in Real-Life Setting of Patients With Atopic Dermatitis: Italian Data From the MEASURE-AD Study
Giuseppe Argenziano(Regione Campania), Giovanna Malara(Azienda ospedaliera "Bianchi-Melacrino-Morelli"), Anna Levi(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Giuliana Gualberti(AbbVie (United States)), Maria Beatrice De Felici Del Giudice(University of Parma), Paola Savoia(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Luca Stingeni(University of Perugia), Santo Raffaele Mercuri(Vita-Salute San Raffaele University), Anna Belloni Fortina(University of Padua), Paolo Amerio(Sunnybrook Health Science Centre), Maria Rita Bongiorno(University of Palermo), Michela Ortoncelli, Valeria Scuderi(AbbVie (United States)), Giuseppe Stinco(Unknown), Luca Bianchi(University of Rome Tor Vergata), Aurora Parodi(Ospedale Policlinico San Martino), Nicola Pimpinelli(University of Florence)
Cited by 6
Related Papers
Clinical End Points and Response Criteria in Mycosis Fungoides and Sézary Syndrome: A Consensus Statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer
|Journal of Clinical Oncology|2011|657
Cigarette Smoking, Body Mass Index, and Stressful Life Events as Risk Factors for Psoriasis: Results from an Italian Case–Control Study
|Journal of Investigative Dermatology|2005|644
Defining early mycosis fungoides
|Journal of the American Academy of Dermatology|2005|543